These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19767827)

  • 1. Exendin-4 exerts its effects through the NGF/p75NTR system in diabetic mouse pancreas.
    Gezginci-Oktayoglu S; Bolkent S
    Biochem Cell Biol; 2009 Aug; 87(4):641-51. PubMed ID: 19767827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice.
    Gezginci-Oktayoglu S; Sacan O; Yanardag R; Karatug A; Bolkent S
    Peptides; 2011 Feb; 32(2):223-31. PubMed ID: 21055431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
    Kwon DY; Kim YS; Ahn IS; Kim DS; Kang S; Hong SM; Park S
    J Pharmacol Sci; 2009 Dec; 111(4):361-71. PubMed ID: 20019445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
    Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
    Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
    Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
    PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 partly ameliorates - hyperglycemia-mediated tissue damage in lungs of streptozotocin-induced diabetic mice.
    Oztay F; Sancar-Bas S; Gezginci-Oktayoglu S; Ercin M; Bolkent S
    Peptides; 2018 Jan; 99():99-107. PubMed ID: 29225158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
    Winzell MS; Ahrén B
    J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
    Kaya-Dagistanli F; Ozturk M
    Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats.
    Barakat G; Moustafa ME; Khalifeh I; Hodroj MH; Bikhazi A; Rizk S
    J Physiol Biochem; 2016 Aug; 73(3):387-394. PubMed ID: 28589533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient beneficial effects of exendin-4 treatment on the function of microencapsulated mouse pancreatic islets.
    Bohman S; Waern I; Andersson A; King A
    Cell Transplant; 2007; 16(1):15-22. PubMed ID: 17436851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
    Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Detroja J; Patel K; Gandhi T; Patel K; Bahekar R; Jain M
    Pharmacol Rep; 2013; 65(4):927-36. PubMed ID: 24145087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exendin-4 on islets from type 2 diabetes patients.
    Lupi R; Mancarella R; Del Guerra S; Bugliani M; Del Prato S; Boggi U; Mosca F; Filipponi F; Marchetti P
    Diabetes Obes Metab; 2008 Jun; 10(6):515-9. PubMed ID: 18201204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats.
    Park S; Hong SM; Sung SR
    Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
    Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
    Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
    Malendowicz LK; Macchi C; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
    Int J Mol Med; 2003 Jun; 11(6):763-6. PubMed ID: 12736719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice.
    Kodama S; Toyonaga T; Kondo T; Matsumoto K; Tsuruzoe K; Kawashima J; Goto H; Kume K; Kume S; Sakakida M; Araki E
    Biochem Biophys Res Commun; 2005 Feb; 327(4):1170-8. PubMed ID: 15652518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.